Why is Walmart CEO Doug McMillon retiring?
How will Trump’s tariff cuts affect food prices?
What caused Berkshire Hathaway’s new stake in Alphabet?
Why did Nvidia’s stock dip before earnings?
How did Disney resolve the YouTube TV blackout?
What impact will Japan’s extra budget have?
Why is Bitcoin falling below $95,000?
AstraZeneca's Investigational Hypertension Drug Shows Significant Blood Pressure Control In Pivotal Trial
benzinga.com/news/health-care/25/11/48761776/astrazenecas-investigational-hypertension-drug-shows-significant-blood-pressure-control-in-pivot
AstraZeneca Plc (NASDAQ:AZN) shared on Monday full data from the Bax24 Phase 3 trial of once-daily 2mg baxdrostat versus placebo, on the reduction of ambulatory systolic blood pressure (SBP), as well as safety and tolerability in participants with resistant hypertension.
• AZN is…
This story appeared on benzinga.com, 2025-11-10 18:39:23.